EXTON, Pa., Feb. 22 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today announced that Colin Broom, MD, vice president and chief scientific officer of ViroPharma, will present at the Susquehanna Financial Group’s ‘Significant Investment Options in Healthcare’ Conference at 2:30 P.M. ET on Thursday, March 1, 2007. The conference is being held at the Omni Berkshire Place in New York.
ViroPharma representatives will also participate in two roundtable discussions during the conference. Steve Gelone, Pharm D, senior director, medical affairs of ViroPharma will participate in a roundtable entitled, “Antibiotic Resistance: Challenges/Opportunities in MRSA, C.difficile, S.pneumonia,” at 8:00 AM ET. Steve Villano, MD, vice president, clinical research and development of ViroPharma will participate in a second roundtable discussion at 10:00 AM ET, entitled, “HCV: What to Target -- Proteases, Polymerases, or Replicases?”
ViroPharma’s corporate presentation and roundtable discussions will be webcast live for investors through www.viropharma.com and available through March 14, 2007.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company’s website at www.viropharma.com.
ViroPharma Incorporated Contacts: William C. Roberts Senior Director, Corporate Communications Phone (610) 321-6288 Robert A. Doody Manager, Corporate Communications Phone (610) 321-6290
ViroPharma Incorporated
CONTACT: William C. Roberts, Senior Director, Corporate Communications,+1-610-321-6288, or Robert A. Doody, Manager, Corporate Communications, +1-610-321-6290, both of ViroPharma Incorporated
Web site: http://www.viropharma.com//
